
Priority for finished pharmaceuticals: How the Bundestag sacrifices cannabis patients — and why hardly anyone saves
The Bundestag has decided on a priority regulation for finished cannabis medicinal products in the GKV Savings Act. Flowers and pharmacy-made preparations slide to the end of the prescription chain. The German Hemp Association calls it "scandalous", the Pharmazeutische Zeitung a "foreign body in the Savings Act". An classification — critical, from the patient's perspective, with figures.
Read more →













